Dudediligence.

Inhibrx Biosciences, Inc

INBXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 288-KRegulation FD disclosure7.019.01
  2. Sep 88-KRegulation FD disclosure and other events7.018.019.01
  3. Aug 1413GPassive stake of 5% or more (13G), filed by Schonfeld Strategic Advisors
  4. Aug 138-KResults of operations2.029.01
  5. Aug 1310-QQuarterly report
  6. Aug 313GPassive stake of 5% or more (13G)
  7. Jul 168-KMaterial agreement and unregistered sale of shares1.012.033.027.019.01
  8. Jun 158-KRegulation FD disclosure and other events7.018.019.01
  9. Jun 38-KShareholder vote5.07
  10. May 148-KResults of operations2.029.01
  11. May 1410-QQuarterly report
  12. May 118-KRegulation FD disclosure and other events7.018.019.01
  13. Apr 218-KRegulation FD disclosure and other events7.018.019.01
  14. Mar 198-KResults of operations2.029.01
  15. Mar 1910-KAnnual report
  16. Feb 238-KRegulation FD disclosure7.019.01
  17. Dec 16, 20258-KRegulation FD disclosure and other events7.018.019.01
  18. Nov 13, 20258-KResults of operations2.029.01
  19. Nov 13, 202510-QQuarterly report
  20. Oct 23, 20258-KRegulation FD disclosure and other events7.018.019.01
  21. Aug 13, 20258-KResults of operations2.029.01
  22. Aug 13, 202510-QQuarterly report
  23. May 28, 2025424B3Prospectus for an offering
  24. May 28, 20258-KShareholder vote5.07
  25. May 14, 2025424B3Prospectus for an offering
  26. May 14, 20258-KResults of operations2.029.01
  27. May 14, 202510-QQuarterly report
  28. Apr 1, 2025424B3Prospectus for an offering
  29. Apr 1, 20258-KOfficer or director change5.02
  30. Mar 17, 2025424B3Prospectus for an offering
  31. Mar 17, 20258-KResults of operations2.029.01
  32. Mar 17, 202510-KAnnual report
  33. Jan 21, 2025424B3Prospectus for an offering
  34. Jan 21, 20258-KRegulation FD disclosure and other events7.018.019.01
  35. Jan 13, 2025424B3Prospectus for an offering
  36. Jan 13, 20258-KMaterial agreement and unregistered sale of shares1.012.033.027.019.01
  37. Nov 14, 2024424B3Prospectus for an offering
  38. Nov 14, 20248-KResults of operations2.029.01
  39. Nov 14, 202410-QQuarterly report
  40. Nov 4, 2024424B3Prospectus for an offering
  41. Nov 4, 20248-KOther events8.01